Comprehensive Expression Analysis Suggests Functional Overlapping of Human FOX Transcription Factors in Cancer |
Zhang, Ya-Li
(Nantong University)
Sun, Feng-Ting (Nantong University) Zhang, Ze (Nantong University) Chen, Xiao-Xu (Nantong University) Liu, Ai-Xiang (Nantong University) Pan, Jing-Jing (Nantong University) Peng, Fei (Nantong University) Zhou, Shuai (Nantong University) Sun, Li-Jun (Nantong University) |
1 | Curtis C, Shah SP, Chin SF, et al (2012). The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature, 486, 346-52. |
2 | Dansen TB, Burgering BM (2008). Unravelling the tumorsuppressive functions of FOXO proteins. Trends Cell Biol, 18, 421-9. DOI |
3 | De BE, Dixon MJ, Small KW, et al (2001). Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotypephenotype correlation. Hum Mol Genet, 10, 1591-600. DOI |
4 | Dong XY, Chen C, Sun X, et al (2006). FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res, 66, 6998-7006. DOI |
5 | Grasso CS, Wu YM, Robinson DR, et al (2012). The mutational landscape of lethal castration-resistant prostate cancer. Nature, 487, 239-43. DOI |
6 | Green MR, Aya-Bonilla C, Gandhi MK, et al (2011). Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer, 50, 313-26. DOI |
7 | Hannenhalli S, Kaestner KH (2009). The evolution of FOX genes and their role in development and disease. Nat Rev Genet, 10, 233-40. |
8 | Hu X, Stern HM, Ge L, et al (2009). Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res, 7, 511-22. DOI |
9 | Kaestner KH, Knochel W, Martinez DE (2000). Unified nomenclature for the winged helix/forkhead transcription factors. Genes Dev, 14, 142-6. |
10 | Katoh M, Igarashi M, Fukuda H, et al (2013). Cancer genetics and genomics of human FOX family genes. Cancer Lett, 328, 198-206. DOI |
11 | Lehmann OJ, Ebenezer ND, Jordan T, et al (2000). Chromosomal duplication involving the forkhead transcription factor gene FOXC1 causes iris hypoplasia and glaucoma. Am J Hum Genet, 67, 1129-35. DOI |
12 | Lin L, Miller CT, Contreras JI, et al (2002). The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res, 62, 5273-9. |
13 | Lokody I (2014). Signalling: FOXM1 and CENPF: co-pilots driving prostate cancer. Nat Rev Cancer, 14, 450-1. |
14 | Mazet F, Yu JK, Liberles DA, et al (2003). Phylogenetic relationships of the FOX (Forkhead) gene family in the Bilateria. Gene, 316, 79-89. DOI |
15 | Nucera C, Eeckhoute J, Finn S, et al (2009). FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res, 15, 3680-9. DOI |
16 | Pohl BS, Knochel W (2005). Of FOX and Frogs: FOX (fork head/ winged helix) transcription factors in Xenopus development. Gene, 344, 21-32. DOI ScienceOn |
17 | Sasahira T, Ueda N, Yamamoto K, et al (2014). Prox1 and FOXC2 act as regulators of lymphangiogenesis and angiogenesis in oral squamous cell carcinoma. PLoS One, 9, 92534. DOI |
18 | Schneider J, Ruschhaupt M, Buness A, et al (2006). Identification and meta-analysis of a small gene expression signature for the diagnosis of estrogen receptor status in invasive ductal breast cancer. Int J Cancer, 119, 2974-9. DOI |
19 | Sulman EP, White PS, Brodeur GM (2004). Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene, 23, 1014-20. DOI |
20 | Tu Q, Brown CT, Davidson EH, et al (2006). Sea urchin Forkhead gene family: phylogeny and embryonic expression. Dev Biol, 300, 49-62. DOI |
21 | Wijchers PJ, Burbach JP, Smidt MP (2006). In control of biology: of mice, men and FOXes. Biochem J, 397, 233-46. DOI |
22 | Wotton KR, Shimeld SM (2006). Comparative genomics of vertebrate FOX cluster loci. BMC Genomics, 7, 271. DOI |
23 | Xu N, Wu SD, Wang H, et al (2012). Involvement of FOXM1 in non-small cell lung cancer recurrence. Asian Pac J Cancer Prev, 13, 4739-43. DOI |
24 | Yang FQ, Yang FP, Li W, et al (2013). FOXl1 inhibits tumor invasion and predicts outcome in human renal cancer. Int J Clin Exp Pathol, 7, 110-22. |
25 | Yu J, Deshmukh H, Payton JE, et al (2011). Array-based comparative genomic hybridization identifies CDK4 and FOXM1 alterations as independent predictors of survival in malignant peripheral nerve sheath tumor. Clin Cancer Res, 17, 1924-34. DOI |
26 | Zheng CH, Quan Y, Li YY, et al (2014). Expression of transcription factor FOXC2 in cervical cancer and effects of silencing on cervical cancer cell proliferation. Asian Pac J Cancer Prev, 15, 1589-95. DOI |
27 | Chen W, Yuan K, Tao ZZ, et al (2011). Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells. Asian Pac J Cancer Prev, 12, 1785-8. |
28 | Bell R, Brice G, Child AH, et al (2001). Analysis of lymphoedemadistichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene. Hum Genet, 108, 546-51. DOI |
29 | Benayoun BA, Caburet S, Veitia RA (2011). Forkhead transcription factors: key players in health and disease. Trends Genet, 27, 224-32. DOI |
30 | Carlsson P, Mahlapuu M (2002). Forkhead transcription factors: key players in development and metabolism. Dev Biol, 250, 1-23. DOI |
31 | Crisponi L, Deiana M, Loi A, et al (2001). The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ ptosis/epicanthus inversus syndrome. Nat Genet, 27, 159-66. DOI |